What is Atomo?
Atomo is a pioneering company leveraging machine learning and advanced analytics to pinpoint individuals and populations facing the most significant unmet medical needs for specific diseases. With a robust 30-year foundation in Healthcare, Life Sciences, and Health Economics and Outcomes Research, Atomo excels at integrating diverse datasets. This capability allows the company to precisely identify patient populations with critical unmet needs and to devise optimal strategies for addressing them, positioning it as a key player in data-driven healthcare solutions.
How much funding has Atomo raised?
Atomo has raised a total of $2.6M across 1 funding round:
Angel/Seed
$2.6M
Angel/Seed (2019): $2.6M, investors not publicly disclosed
What's next for Atomo?
The substantial enterprise-level backing and recent strategic investment signal a pivotal growth phase for Atomo. This infusion of capital is expected to accelerate the company's development and deployment of its advanced analytics platforms. Future initiatives will likely focus on expanding its market reach, forging new strategic partnerships within the healthcare ecosystem, and further refining its machine learning algorithms to enhance the identification and addressing of unmet medical needs. The company's trajectory suggests a strong emphasis on innovation and market leadership in the health tech sector.
See full Atomo company page
